Abstract

BackgroundRecently, the compatible solute 1, 4, 5, 6-tetrahydro-2-methyl-4-pyrimidinecarboxylic acid (ectoine) has attracted considerable interest due to its great potential as a protecting agent. To overcome the drawbacks of high salinity in the traditional bioprocess of ectoine using halophilic bacteria, various attempts have been made to engineer ectoine biosynthesis in nonhalophilic bacteria. Unfortunately, the yields of ectoine in these producers are still low and hardly meet the demands of large scale production. In this paper, the whole-cell biocatalytic process using aspartate and glycerol as substrates was tried for high production of ectoine in nonhalophilic bacteria.ResultsThe ectoine genes ectABC from the halophilic bacterium Halomonas elongata were successfully introduced into Escherichia coli K-12 strain BW25113 under the arabinose-inducible promoter. To our delight, a large amount of ectoine was synthesized and excreted into the medium during the course of whole-cell biocatalysis, when using aspartate and glycerol as the direct substrates. At the low cell density of 5 OD/mL in flask, under the optimal conditions (100 mM sodium phosphate buffer (pH 7.0), 100 mM sodium aspartate, 100 mM KCl and 100 mM glycerol), the concentration of extracellular ectoine was increased to 2.67 mg/mL. At the high cell density of 20 OD/mL in fermentor, a maximum titre of 25.1 g/L ectoine was achieved in 24 h. Meanwhile, the biomass productivity of ectoine is as high as 4048 mg per gram dry cell weight (g DCW)−1, which is the highest value ever reported. Furthermore, it was demonstrated that the same batch of cells could be used for at least three rounds. Finally, a total yield of 63.4 g ectoine was obtained using one litre cells.ConclusionUsing aspartate and glycerol as the direct substrates, high production of ectoine was achieved by the whole-cell biocatalysis in recombinant E. coli. Multiple rounds of whole-cell biocatalysis were established to further improve the production of ectoine. Our study herein provided a feasible biosynthesis process of ectoine with potential applications in large-scale industrial production.

Highlights

  • The compatible solute 1, 4, 5, 6-tetrahydro-2-methyl-4-pyrimidinecarboxylic acid has attracted considerable interest due to its great potential as a protecting agent

  • L-aspartate-beta-semialdehyde is first transaminated to generate L-2, 4-diaminobutyric acid (DABA) by DABA transaminase (EctB), which is converted to N-γacetyldiaminobutyric acid by DABA-N-γ-acetyltransferase (EctA)

  • The results of SDS-PAGE and mass spectrometric indicated that the ectABC gene cassette from H. elongata was successfully expressed in E. coli K strain BW25113

Read more

Summary

Introduction

The compatible solute 1, 4, 5, 6-tetrahydro-2-methyl-4-pyrimidinecarboxylic acid (ectoine) has attracted considerable interest due to its great potential as a protecting agent. Many types of compatible solutes have been found, which can be He et al Microbial Cell Factories (2015) 14:55 versatile commercial applications in the pharmaceutical industry. It can be used as protein stabiliser, PCR enhancer, drying protective agent for microorganisms, and cosmetic additive [8,9,10]. The biosynthetic pathway of ectoine has been fully elucidated [11,12] It shares the first two enzymatic steps with the biosynthesis of amino acids of the aspartate family: the synthesis of Laspartate-phosphate through the ATP-dependent phosphorylation of L-aspartate by aspartate kinase (Ask), and the synthesis of L-aspartate-beta-semialdehyde through an NADPH-dependent reaction by L-aspartatebeta-semialdehyde-dehydrogenase (Asd). The ectABC gene cluster involved in the biosynthesis of ectoine has been founded and characterised from many microorganisms [13]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call